Sex influence on outcomes of patients with systemic sclerosis–associated interstitial lung disease: a EUSTAR database analysis
Author:
Campochiaro Corrado1ORCID, Hoffmann-Vold Anna-Maria2ORCID, Avouac Jerome3, Henes Jörg4ORCID, de Vries-Bouwstra Jeska5, Smith Vanessa6ORCID, Siegert Elise7, Airò Paolo8, Oksel Fahrettin9, Pellerito Raffaele10, Vanthuyne Marie11, Pozzi Maria Rosa12, Inanc Murat13, Sibilia Jean14, Gabrielli Armando15, Distler Oliver16ORCID, Allanore Yannick3, Cerinic Marco Matucci, Walker Ulrich, Iannone Florenzo, Becvar Radim, Cuomo Giovanna, Montecucco C, Carreira Patricia E, Iudici Michele, Kucharz Eugene J, Zanatta Elisabetta, Bancel Pr Dominique Farge, Hesselstrand Roger, Balbir-Gurman Alexandra, Pellerito Raffaele, Bertoldo Eugenia, Damjanov Nemanja, Granollers Vera Ortiz-Santamaria, Heitmann Stefan, Salvador Maria João, Stamenkovic Bojana, Selmi Carlo Francesco, Herrick Ariane, ller-Ladner Ulf Mü, Engelhart Merete, Riccieri Valeria, Ionescu Ruxandra Maria, Gheorghiu Ana Maria, Sunderkötter Cord, Distler Jörg, Ingegnoli Francesca, Mouthon Luc, Cantatore Francesco Paolo, Ullman Susanne, Wiland Piotr, Vanthuyne Marie, Saar Petra, Herrmann Kristine, De Langhe Ellen, Mayer Miroslav, Yavuz Sule, de Souza Müller Carolina, Zenone Thierry, Vacca Alessandra, Solanki Kamal, Rosato Edoardo, Yargucu Fahrettin Oksel Figen, Tanaseanu Cristina-Mihaela, Foti Rosario, Furst Daniel E, Adler Peter Villiger Sabine, Martín Jorge Juan González, Litinsky Ira, Del Galdo Francesco, Seskute Goda, Saketkoo Lesley Ann, Kerzberg Eduardo, Castellví Ivan, Spertini François, Hsu Vivien M, Martin Thierry, Schmeiser Tim, Majewski Dominik, Bernardino Vera, Puttini Piercarlo Sarzi, Moroncini Gianluca, Stork Jiri, Hachulla Eric, de la Pena Lefebvre Paloma Garcıa, Limonta Massimiliano, Sfikakis Petros, Cutolo Maurizio, Ananieva Lidia P, Czirjak Laszlo, Denton Christopher, De Luca Giacomo, Dagna Lorenzo,
Affiliation:
1. Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University , Milan, Italy 2. Department of Rheumatology, Oslo University Hospital , Oslo, Norway 3. Service de Rheumatologie, Cochin Hospital, APHP, Universite Paris Descartes , Paris, France 4. Centre for Interdisciplinary Clinical Immunology, Rheumatology and Auto-Inflammatory Diseases and Department of Internal Medicine II (Haematology, Oncology, Immunology and Rheumatology), University Hospital Tuebingen , Tuebingen, Germany 5. Department of Rheumatology, Leiden University Medical Center , Leiden, The Netherlands 6. Department of Rheumatology, Ghent University Hospital , Ghent, Belgium 7. Department of Rheumatology and Clinical Immunology, Charité-Universitatsmedizin Berlin , Berlin, Germany 8. Rheumatology and Clinical Immunology Department, Spedali Civili , Brescia, Italy 9. Department of Internal Medicine, Division of Rheumatology, Ege University, Faculty of Medicine , Izmir, Turkey 10. Rheumatology Unit, Ospedale Mauriziano , Torino, Italy 11. Department of Rheumatology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain , Louvain-la-Neuve, Belgium 12. Rheumatology Unit, S. Gerardo Hospital , Monza, Italy 13. Division of Rheumatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul, Turkey 14. Service de Rheumatologie, RESO: Centre de Reference des Maladies Autoimmunes Systémiques Rares Est Sud-Ouest, Hôpital De Hautepierre , Strasbourg, France 15. Department of Clinical and Molecular Sciences, Universita′ Politecnica Delle Marche , Ancona, Italy 16. Department of Rheumatology, University Hospital Zurich, University of Zurich , Zurich, Switzerland
Abstract
Abstract
Objective
Interstitial lung disease (ILD) is the leading cause of morbidity and mortality in systemic sclerosis (SSc) patients. We aimed to investigate the impact of sex on SSc-ILD.
Methods
EUSTAR SSc patients with radiologically confirmed ILD and available percentage predicted forced vital capacity (%pFVC) were included. Demographics and disease features were recorded. A change in %pFVC over 12 months (s.d. 6) (cohort 1) was classified into stable (≤4%), mild (5–9%) and large progression (≥10%). In those with 2-year longitudinal %pFVC (cohort 2), the %pFVC change at each 12-month (s.d. 6) interval was calculated. Logistic regression analyses [odds ratio (OR) and 95% CI] and Cox proportional hazards models adjusted for age and %pFVC were applied.
Results
A total of 1136 male and 5253 female SSc-ILD patients were identified. Males were significantly younger, had a shorter disease duration, had a higher prevalence of CRP elevation and frequently had diffuse cutaneous involvement. In cohort 1 (1655 females and 390 males), a higher percentage of males had stable ILD (74.4% vs 69.4%, P = 0.056). In multivariable analysis, disease duration and %pFVC [OR 0.99 (95% CI 0.98, 0.99) and OR 0.97 (95% CI 0.95, 0.99), respectively] in males and age, %pFVC and anti-centromere [OR 1.02 (95% CI 1.00, 1.04), OR 0.97 (95% CI 0.96, 0.98) and OR 0.39 (95% CI 0.245, 0.63), respectively] in females were associated with large progression. The 1-year mortality rate was higher in males (5.1% vs 2.5%, P = 0.013). In cohort 2 (849 females and 209 males), a higher percentage of females showed periods of large progression (11.7% vs 7.7%, P = 0.023), the percentage of patients with none, one or two periods of worsening was not different. The overall death rate was 30.9% for males and 20.4% in females (P < 0.001). In the survival analysis, male sex was a predictor of mortality [OR 1.95 (95% CI 1.66, 2.28)].
Conclusions
Male SSc-ILD patients have a poorer prognosis and sex-specific predictors exist in SSc-ILD.
Publisher
Oxford University Press (OUP)
Subject
Pharmacology (medical),Rheumatology
Reference35 articles.
1. Systemic sclerosis;Denton;Lancet,2017 2. Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities;Varga;J Scleroderma Relat Disord,2017 3. The effect of male sex on survival in systemic sclerosis;Hussein;J Rheumatol,2014 4. Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database;Carreira;Clin Exp Rheumatol,2018 5. Clinical and epidemiological differences between men and women with systemic sclerosis: a study in a Spanish systemic sclerosis cohort and literature review;Dapena;Clin Exp Rheumatol,2017
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|